Patents-Review.com
ClassID:

117477 ⎘

C12Y310/01001 - CPC Classification

Classification description:

acting on sulfur-nitrogen bonds (3.10.1) N-Sulfoglucosamine sulfohydrolase (3.10.1.1)

Recent Application in this class:
#1
20260092264
2026-04-02

NOVEL PROCESS FOR PURIFYING HEPARAN-N-SULFATASE

 #2
20250375506
2025-12-11

CNS DELIVERY OF THERAPEUTIC AGENTS

 #3
20250312423
2025-10-09

Methods for Delivery of Polynucleotides by Adeno-Associated Virus for Lysosomal Storage Disorders

 #4
20250257338
2025-08-14

GLYCOPROTEIN HAVING REDUCED NUMBER OF MANNOSE-6-PHOSPHATES

 #5
20250243476
2025-07-31

PLANT LECTINS AS CARRIERS OF ASSOCIATED DRUG SUBSTANCES INTO ANIMAL AND HUMAN CELLS

 #6
20250228907
2025-07-17

COMPOSITIONS AND METHODS FOR TREATING METACHROMATIC LEUKODYSTROPHY DISEASE AND RELATED DISORDERS

 #7
20250213730
2025-07-03

GENE THERAPY FOR DISEASES WITH CNS MANIFESTATIONS

 #8
20250161417
2025-05-22

METHODS AND COMPOSITIONS FOR CNS DELIVERY OF ARYLSULFATASE A

 #9
20250161354
2025-05-22

METHODS FOR TREATING INHERITED METABOLIC DISORDERS

 #10
20250121040
2025-04-17

METHODS AND COMPOSITIONS FOR CNS DELIVERY OF IDURONATE-2-SULFATASE

 #11
20250041445
2025-02-06

GENE THERAPY FOR TREATMENT OF MUCOPOLYSACCHARIDOSIS IIIA

 #12
20250034533
2025-01-30

Compositions And Methods For Treating Mucopolysaccharidosis IIIA

 #13
20240150736
2024-05-09

FUSION PROTEINS COMPRISING SULFOGLUCOSAMINE SULFOHYDROLASE ENZYMES AND METHODS THEREOF

 #14
20230279430
2023-09-07

GENE THERAPY FOR MUCOPOLYSACCHARIDOSIS IIIA

 #15
20230165942
2023-06-01

CNS DELIVERY OF THERAPEUTIC AGENTS

 #16
20230140157
2023-05-04

Plant lectins as carriers of associated drug substances into animal and human cells

 #17
20230133201
2023-05-04

METHODS AND MATERIALS FOR DISSEMINATING A PROTEIN THROUGHOUT THE CENTRAL NERVOUS SYSTEM

 #18
20230124994
2023-04-20

COMPOSITIONS AND METHODS FOR THE TREATMENT OF SANFILIPPO DISEASE AND OTHER DISORDERS

 #19
20230062800
2023-03-02

Fusion proteins comprising sulfoglucosamine sulfohydrolase enzymes and methods thereof

 #20
20230026836
2023-01-26

Methods and compositions for CNS delivery of iduronate-2-sulfatase

 #21
20220348672
2022-11-03

METHODS AND COMPOSITIONS FOR INCREASING ENZYME ACTIVITY IN THE CNS

 #22
20220133863
2022-05-05

TREATMENT OF SANFILIPPO SYNDROME TYPE B

 #23
20220133862
2022-05-05

Methods and compositions for CNS delivery of heparan N-sulfatase

 #24
20220064288
2022-03-03

Anti-Human Transferrin Receptor Antibody Permeating Blood-Brain Barrier

 #25
20220042043
2022-02-10

RECOMBINANT VECTORS FOR THE LONG TERM TREATMENT OF MUCCHOPOLYSACHARIDOSIS

 #26
20210324354
2021-10-21

Sulfamidase (SGSH) variants, vectors, compositions and methods and uses for treating mucopolysaccharidosis type IIIA (MPS IIIA)

 #27
20210198640
2021-07-01

Fusion proteins comprising enzyme replacement therapy enzymes

 #28
20200405825
2020-12-31

Methods and compositions for CNS delivery of arylsulfatase A

 #29
20200308292
2020-10-01

METHODS AND COMPOSITIONS FOR INCREASING ENZYME ACTIVITY IN THE CNS

 #30
20200291429
2020-09-17

Gene therapy for mucopolysaccharidosis IIIA

 #31
20200277584
2020-09-03

FUSION PROTEINS COMPRISING ENZYME REPLACEMENT THERAPY ENZYMES

 #32
20200113981
2020-04-16

CNS delivery of therapeutic agents

 #33
20200046810
2020-02-13

Methods and compositions for CNS delivery of iduronate-2-sulfatase

 #34
20200000887
2020-01-02

Methods for delivery of polynucleotides by adeno-associated virus for lysosomal storage disorders

 #35
20190249155
2019-08-15

Fusion proteins comprising enzyme replacement therapy enzymes

 #36
20190183984
2019-06-20

Methods and compositions for CNS delivery of heparan n-sulfatase

 #37
20180320152
2018-11-08

MODIFIED SULFAMIDASE AND PRODUCTION THEREOF

 #38
20180258408
2018-09-13

MODIFIED LYSOSOMAL PROTEIN AND PRODUCTION THEREOF

 #39
20180207242
2018-07-26

Treatment of cognitive impairment of mucopolysaccharidosis type IIIA by intrathecal delivery of heparan N-sulfatase

 #40
20180193431
2018-07-12

Products and Methods for Delivery of Polynucleotides by Adeno-Associated Virus for Lysosomal Storage Disorders

 #41
20180171012
2018-06-21

Anti-human transferrin receptor antibody permeating blood-brain barrier

 #42
20180085438
2018-03-29

Therapeutic fusion protein comprising an alpha-n-acetylglucosaminidase and a lysosomal targeting moiety

 #43
20180071401
2018-03-15

Intranasal administration of guanidinylated aminoglycosides

 #44
20180071212
2018-03-15

Methods and compositions for CNS delivery of arylsulfatase A

 #45
20170267987
2017-09-21

Plant lectins as carriers of associated drug substances into animal and human cells

 #46
20170042978
2017-02-16

CNS delivery of therapeutic agents

 #47
20170042977
2017-02-16

METHODS AND COMPOSITIONS FOR CNS DELIVERY OF HEPARAN N-SULFATASE

 #48
20160230155
2016-08-11

Modified sulfamidase and production thereof

 #49
20160175406
2016-06-23

PRODUCTS AND METHODS FOR DELIVERY OF POLYNUCLEOTIDES BY ADENO-ASSOCIATED VIRUS FOR LYSOSOMAL STORAGE DISORDERS

 #50
20160122731
2016-05-05

Therapeutic strategies to treat CNS pathology in mucopolysaccharidoses

 #51
20160083707
2016-03-24

Plant lectins as carriers of associated drug substances into animal and human cells

 #52
20160015822
2016-01-21

Intranasal administration of guanidinylated aminoglycosides

 #53
20150023956
2015-01-22

METHODS AND COMPOSITIONS FOR INCREASING ENZYME ACTIVITY IN THE CNS

 #54
20130302308
2013-11-14

Therapeutic strategies to treat CNS pathology in mucopolysaccharidoses

 #55
20130295077
2013-11-07

Treatment of Sanfilippo syndrome type B by intrathecal administration of alpha-n-acetylglucosaminidase

 #56
20130039888
2013-02-14

PRODUCTS AND METHODS FOR DELIVERY OF POLYNUCLEOTIDES BY ADENO-ASSOCIATED VIRUS FOR LYSOSOMAL STORAGE DISORDERS

 #57
20120014936
2012-01-19

Methods and compositions for CNS delivery of heparan N-sulfatase